SDS

Monsanto Company, Lawn & Garden Products
Page: 2 / 10
Roundup® Ready-To-Use Extended Control Weed & Grass
Killer Plus Weed Preventer II
Version: 1.0 Effective date: 05/13/2015
Nonanoic and related fatty acids; {Pelargonic and related fatty acids}
Isopropylamine salt of N-(phosphonomethyl)glycine; {Isopropylamine salt of glyphosate}
Ammonium salt of 2-[4,5-dihydro-4-methyl-4-(1-methyl)-5-oxo-1H-imidazol-2-yl]-5-methyl-3-pyridinecarboxylic
acid; {Ammonium salt of imazapic}
Composition
COMPONENT CAS No. % by weight (approximate)
Pelargonic and related fatty acids 112-05-0 2
Isopropylamine salt of glyphosate 38641-94-0 1
Ammonium salt of imazapic 104098-49-9 0.017
Other ingredients 96.983
The specific chemical identity is being withheld because it is trade secret information of Monsanto Company.
4. FIRST AID MEASURES
Use personal protection recommended in section 8.
4.1. Description of first aid measures
4.1.1. Eye contact: If in eyes, hold eye open and rinse slowly and gently for 15-20 minutes. Remove
contact lenses, if present, after first 5 minutes, then continue rinsing. Call a poison control center or
doctor for treatment advice.
4.1.2. Skin contact: Take off contaminated clothing. Rinse skin immediately with plenty of water for 15-
20 minutes. Call a poison control center or doctor for treatment advice.
4.1.3. Inhalation: If inhaled, move person to fresh air. If person is not breathing, call emergency number or
ambulance, then give artificial respiration, preferably mouth-to-mouth, if possible. Call a poison
control center or doctor for treatment advice.
4.1.4. Ingestion: Call poison control center or doctor immediately for treatment advice. Have person sip a
glass of water if able to swallow. Do not induce vomiting unless told to do so by the poison center or
doctor. Do not give anything by mouth to an unconscious person.
4.2. Most important symptoms and effects, both acute and delayed
4.2.1. Eye contact, short term: Not expected to produce significant adverse effects when recommended
use instructions are followed.
4.2.2. Skin contact, short term: Not expected to produce significant adverse effects when recommended
use instructions are followed.
4.2.3. Inhalation, short term: Not expected to produce significant adverse effects when recommended use
instructions are followed.
4.2.4. Single ingestion: Not expected to produce significant adverse effects when recommended use
instructions are followed.
4.3. Indication of any immediate medical attention and special treatment needed
4.3.1. Advice to doctors: This product is not an inhibitor of cholinesterase.
4.3.2. Antidote: Treatment with atropine and oximes is not indicated.
5. FIRE-FIGHTING MEASURES
5.1. Extinguishing media
5.1.1. Recommended: Water, foam, dry chemical, carbon dioxide (CO2)
5.2. Special hazards
5.2.1. Unusual fire and explosion hazards